Uterine carcinosarcoma: A review of the literature
- 1 June 2015
- journal article
- review article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 137 (3), 581-588
- https://doi.org/10.1016/j.ygyno.2015.03.041
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- A multi-institutional cohort study of adjuvant therapy in stage I–II uterine carcinosarcomaGynecologic Oncology, 2012
- A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II ConsortiaGynecologic Oncology, 2012
- Uterine CarcinosarcomaClinical Obstetrics and Gynecology, 2011
- The role of lymphadenectomy in uterine carcinosarcomas (malignant mixed mullerian tumours): a critical literature reviewArchiv für Gynäkologie, 2010
- A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: A trial of the Chicago, PMH, and California Phase II ConsortiaGynecologic Oncology, 2010
- The impact of multi-modal therapy on survival for uterine carcinosarcomasGynecologic Oncology, 2010
- A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancerGynecologic Oncology, 2009
- Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcomaGynecologic Oncology, 2007
- A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I–IV carcinosarcoma (CS) of the uterusGynecologic Oncology, 2007
- Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomasInternational Journal of Gynecologic Cancer, 2002